1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
HOUSE_OVERSIGHT_024003_sub_001 - HOUSE_OVERSIGHT_024102
f contraction and could see a re-set that begins to shift the industry to more normalized conditions due to the recent stronger IPO and M&A markets. Life Sciences Venture Fundraising Investments into Biopharma and Medical Devices Life Sciences Venture Fundraising - Dollars Raised ($B) ** Life Sciences Venture Financings — $ Invested ($B) and
No connected entities